Skip to main content
Skip to main content
SASS logo

M.D. Sass Concentrated Equities ETF (SASS) Stock Analysis

$24.46 -$0.2802 (-1.13%)
MCap: $75.1M| Vol: 832|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

M.D. Sass Concentrated Equities ETF (SASS) trades at $24.46. M. D. Sass Concentrated Equities ETF (SASS) is an actively managed ETF focused on long-term capital appreciation through a concentrated portfolio of U. Market cap: $75.1M, Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026
M.D. Sass Concentrated Equities ETF (SASS) is an actively managed ETF focused on long-term capital appreciation through a concentrated portfolio of U.S. equities. The fund selects investments based on fundamental research.

Analyst Coverage for SASS: SASS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SASS against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the SASS film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Not yet rated

Not enough scored data yet to form a council read on SASS.

How is this calculated? →
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

M.D. Sass Concentrated Equities ETF (SASS) Financial Services Profile

CEOAri D. Sass
HeadquartersNew York, US
IPO Year2026

M.D. Sass Concentrated Equities ETF is an actively managed fund employing fundamental research to build a concentrated portfolio of U.S. equities, seeking long-term capital appreciation. Operating within the asset management sector, the fund offers investors exposure to a curated selection of domestic companies.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for SASS?

As of Mar 17, 2026 — figures reflect the data available on that date.

M.D. Sass Concentrated Equities ETF presents a focused investment strategy targeting long-term capital appreciation through a concentrated portfolio of U.S. equities. The fund's value proposition hinges on the expertise of its management team in identifying undervalued or high-growth companies through fundamental research. A key driver is the potential for outperformance compared to broader market indices due to the concentrated nature of the portfolio. However, this concentration also introduces higher volatility and idiosyncratic risk. The fund's success depends on the continued accuracy of its stock selection process and its ability to adapt to changing market conditions. Investors should carefully consider their risk tolerance and investment horizon before investing in SASS, given its concentrated approach and potential for fluctuations in value. As of 2026-03-17, the fund has a market capitalization of $75.1M and does not offer a dividend yield.

Based on FMP financials and quantitative analysis

SASS Key Highlights

Actively managed ETF seeking long-term capital appreciation.

  • Concentrated portfolio of U.S. equities allows for potentially higher returns but also increased volatility.
  • Investment selection process driven by fundamental research.
  • ETF structure offers diversification within a specific investment strategy, combined with liquidity and transparency.
  • Market capitalization of $75.1M as of 2026-03-17.

Who Are SASS's Competitors?

SASS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
IWM iShares Russell 2000 ETF $297.64 -1.35% $81.9B 47
SPY SPDR S&P 500 ETF $762.60 -0.84% $812B 46
QQQ Invesco QQQ Trust, Series 1 $710.93 -0.72% $507B 41
EEA The European Equity Fund, Inc. $11.15 -0.59% $74.7M 67
HNNA Hennessy Advisors, Inc. $9.89 -1.30% $78.2M 81
ETHT ProShares - Ultra Ether ETF $12.57 +19.94% $92.2M 68
TPZ Tortoise Electrification Infrastructure ETF $21.62 -0.18% $127M 70
CHECU Chenghe Acquisition III Co. Units $10.25 +0.39% $134M 67

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SASS's Key Strengths?

Actively managed approach allows for flexible investment decisions.

  • Concentrated portfolio can generate higher returns.
  • Experienced investment management team.
  • Transparent ETF structure.

What Are SASS's Weaknesses?

Concentrated portfolio increases volatility and risk.

  • Performance is highly dependent on stock selection skills.
  • Smaller market capitalization compared to larger ETF providers.
  • No dividend yield.

What Could Drive SASS Stock Higher?

Potential for outperformance in specific market conditions due to concentrated portfolio.

  • Continued focus on fundamental research to identify undervalued companies.
  • Expansion of distribution channels to reach a wider range of investors.

What Are the Key Risks for SASS?

Market downturns can negatively impact AUM and investment performance.

  • Increased competition from passive ETFs and other actively managed funds.
  • Dependence on the stock selection skills of the investment management team.
  • Concentrated portfolio increases volatility and risk.

What Are the Growth Opportunities for SASS?

  • Expansion of distribution channels: M.D. Sass Concentrated Equities ETF can grow by expanding its distribution channels to reach a wider range of investors. This could involve partnering with additional brokerage firms, financial advisors, and online investment platforms. The increasing accessibility of ETFs through various investment platforms presents a significant opportunity to attract new investors. By broadening its distribution network, the fund can increase its assets under management and generate higher revenue. This expansion could be implemented over the next 1-2 years, potentially increasing market share by 5-10%.
  • Development of new investment strategies: M.D. Sass Concentrated Equities ETF can develop new investment strategies to cater to different investor needs and preferences. This could involve launching new ETFs that focus on specific sectors, industries, or investment themes. The growing demand for thematic investing presents an opportunity to create specialized ETFs that align with current market trends. By diversifying its product offerings, the fund can attract a broader range of investors and increase its assets under management. New strategies could be launched within the next 2-3 years, targeting specific market segments.
  • Enhancement of marketing and communication efforts: M.D. Sass Concentrated Equities ETF can enhance its marketing and communication efforts to increase brand awareness and attract new investors. This could involve creating educational content, participating in industry events, and leveraging social media platforms. The increasing importance of online marketing and investor education presents an opportunity to connect with potential investors and build trust. By improving its marketing and communication efforts, the fund can increase its visibility and attract more assets. Enhanced marketing could begin immediately with measurable results within 6-12 months.
  • Strategic partnerships and acquisitions: M.D. Sass Concentrated Equities ETF can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This could involve partnering with other asset management firms, technology providers, or distribution platforms. The increasing consolidation within the asset management industry presents an opportunity to acquire complementary businesses or technologies. By forming strategic partnerships and acquisitions, the fund can enhance its competitive position and accelerate its growth. Partnerships could be explored and potentially finalized within the next 1-2 years.
  • Focus on sustainable and responsible investing: M.D. Sass Concentrated Equities ETF can incorporate sustainable and responsible investing (SRI) principles into its investment process to attract investors who prioritize environmental, social, and governance (ESG) factors. The growing demand for SRI investments presents an opportunity to create ETFs that align with these values. By integrating ESG considerations into its investment selection process, the fund can attract a new segment of investors and enhance its reputation. This integration could be implemented progressively over the next year, with dedicated SRI products launched within 2-3 years.

What Are SASS's Competitive Advantages?

  • Expertise of the investment management team in fundamental research.
  • Established track record of generating returns.
  • Brand reputation and investor trust.

What Does SASS Do?

M.D. Sass Concentrated Equities ETF is an actively managed exchange-traded fund (ETF) designed to provide investors with long-term capital appreciation. The fund achieves this objective by investing in a concentrated portfolio of U.S. equities. The investment selection process is driven by rigorous fundamental research, focusing on identifying companies with strong growth potential and sustainable competitive advantages. The ETF's concentrated approach means that it typically holds a smaller number of stocks compared to broader market index funds, allowing for potentially higher returns but also increased volatility. The fund is managed by a team of experienced investment professionals who conduct in-depth analysis of individual companies and macroeconomic trends to make informed investment decisions. M.D. Sass Concentrated Equities ETF is available to investors through various brokerage platforms and financial advisors. The ETF structure offers investors the benefits of diversification within a specific investment strategy, combined with the liquidity and transparency of an exchange-traded product. The fund's focus on U.S. equities provides investors with exposure to the domestic economy and potential growth opportunities within the U.S. market. The ETF is headquartered in New York, reflecting its focus on U.S. equities and the domestic financial market.

What Products and Services Does SASS Offer?

  • Actively manages an exchange-traded fund (ETF).
  • Invests in a concentrated portfolio of U.S. equities.
  • Seeks long-term capital appreciation.
  • Employs fundamental research to select investments.
  • Offers investors exposure to a curated selection of domestic companies.
  • Provides liquidity and transparency through the ETF structure.
  • Targets investors seeking potentially higher returns with increased volatility.

How Does SASS Make Money?

  • Generates revenue through management fees charged on assets under management (AUM).
  • AUM growth is driven by investment performance and investor inflows.
  • Expenses include investment management fees, administrative costs, and marketing expenses.

What Industry Does SASS Operate In?

M.D. Sass Concentrated Equities ETF operates within the asset management industry, which is characterized by intense competition and evolving investor preferences. The industry is influenced by macroeconomic trends, regulatory changes, and technological advancements. The rise of passive investing and the increasing demand for specialized investment strategies are shaping the competitive landscape. M.D. Sass Concentrated Equities ETF differentiates itself through its actively managed, concentrated approach, targeting investors who seek potentially higher returns and are comfortable with increased volatility. The fund competes with other actively managed ETFs and mutual funds that focus on U.S. equities.

Who Are SASS's Key Customers?

  • Individual investors seeking long-term capital appreciation.
  • Financial advisors who recommend ETFs to their clients.
  • Institutional investors looking for exposure to U.S. equities.
AI Confidence: 81% Updated: Mar 17, 2026

SASS Valuation & Market Position

With a $75.1M market cap, M.D. Sass Concentrated Equities ETF sits in the micro-cap segment of the market.

ROE 0%

Key Financial Metrics

Return on equity for M.D. Sass Concentrated Equities ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. SASS trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

SASS Financials

Bull Case vs Bear Case

Bull Case

  • Actively managed approach allows for flexible investment decisions.
  • Concentrated portfolio can generate higher returns.
  • Experienced investment management team.
  • Transparent ETF structure.

Bear Case

  • Concentrated portfolio increases volatility and risk.
  • Performance is highly dependent on stock selection skills.
  • Smaller market capitalization compared to larger ETF providers.
  • No dividend yield.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

SASS Latest News

No recent news available for SASS.

SASS Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SASS.

Price Targets

Wall Street price target analysis for SASS.

SASS MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates SASS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Ari D. Sass

CEO

Ari D. Sass is the CEO of M.D. Sass Concentrated Equities ETF. His background includes extensive experience in the financial services industry, with a focus on asset management and investment strategies. He has held various leadership positions at M.D. Sass, contributing to the firm's growth and development. His expertise lies in identifying investment opportunities and managing portfolios to achieve long-term capital appreciation. He is actively involved in the firm's research and investment decision-making processes.

Track Record: Under Ari D. Sass's leadership, M.D. Sass Concentrated Equities ETF has focused on delivering long-term value to investors through its concentrated equity strategy. He has overseen the fund's investment selection process and has been instrumental in navigating market fluctuations. His strategic decisions have contributed to the fund's performance and its ability to attract and retain investors.

SASS Financial Services Stock FAQ

What does M.D. Sass Concentrated Equities ETF do?

M.D. Sass Concentrated Equities ETF is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing in a concentrated portfolio of U.S. equities. The fund's investment strategy is based on fundamental research, focusing on identifying companies with strong growth potential and sustainable competitive advantages.

What do analysts say about SASS stock?

As of 2026-03-17, there is no readily available analyst consensus on SASS stock, likely due to its nature as an ETF rather than an individual company stock. Key valuation metrics are primarily focused on the fund's net asset value (NAV) and its performance relative to its benchmark.

What are the main risks for SASS?

The main risks for M.D. Sass Concentrated Equities ETF include market risk, concentration risk, and management risk. Market risk refers to the potential for the overall stock market to decline, which would negatively impact the fund's value.

How is M.D. Sass Concentrated Equities ETF adapting to fintech disruption?

M.D. Sass Concentrated Equities ETF is likely adapting to fintech disruption by leveraging technology to enhance its investment research and portfolio management processes. This could involve using artificial intelligence and machine learning to identify investment opportunities and improve risk management. The fund may also be exploring partnerships with fintech companies to offer new products and services to investors.

What is M.D. Sass Concentrated Equities ETF's approach to responsible investing?

M.D. Sass Concentrated Equities ETF's approach to responsible investing is currently Unknown. While the fund's primary focus is on long-term capital appreciation through fundamental research-driven stock selection, it may be considering incorporating environmental, social, and governance (ESG) factors into its investment process.

What are the key factors to evaluate for SASS?

Evaluate SASS on fundamentals, analyst consensus, and risk factors. M.D. Sass Concentrated Equities ETF presents a focused investment strategy targeting long-term capital appreciation through a concentrated portfolio of U.S. Not financial advice.

How frequently does SASS data refresh on this page?

SASS's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven SASS's recent stock price performance?

M.D. Sass Concentrated Equities ETF (SASS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Actively managed approach allows for flexible investment decisions. See the News tab for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • AI analysis pending for SASS.
  • Information is based on available data as of 2026-03-17.
Data Sources

Popular Stocks

More Stocks We Cover